Diagnosis
of pleural mesothelioma
-
History
of exposure to asbestos.
-
X-Ray
chest - Chest radiographs reveal a variable amount of fluid,
with pleural thickening or pleural nodules, often several
centimeters in diameter, imposing a scalloped appearance.
Mediastinum shift might be visible.
-
CT
scan, MRI can detect the extent of the disease
-
Thoracocentasis
reveals malignant cells in up to 30% cases and high content
of hyaluronic acid.
-
Gallium
scan
-
Echocardiography
and ECG may reveal cardiac abnormality and pericardial
involvement
-
Thoracoscopy
or thoracotomy with biopsy is needed to confirm the
diagnosis.
Diagnosis
of peritoneal mesothelioma:
Treatment:
Treatment
of mesothelioma is often very difficult due to its diffuse mass.
Treatment modalities include-
-
Surgical
resection
-
A
combination of Radiotherapy using Iodine-125 or Iridium-192
implants and surgery
-
Radiotherapy
alone
-
Radiotherapy
and Chemotherapy
-
Combination
chemotherapy- Chemotherapy can be given either intravenously
or intracavitary (chemotherapeutic agent put inside pleura
or peritoneum). Doxorubicin , 5-azacytidine, cisplatin,
mitomycin, 5-FU, methyl CCNU, and actinomycin
all have been used in different combinations.
-
Biological
therapy - Human recombinant IFN-a was first shown to
potentiate the effect of chemotherapy. Interleukine-2 has
also some beneficial effect in patients with mesothelioma.
-
New
developments - Adding pemetrexed (Alimta)
to cisplatin improved survival for patients with malignant
pleural mesothelioma, according to the results of a
randomized phase III trial published in the July 15 2003,
issue of the Journal of Clinical Oncology.
|